Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [906]
News [2550]
Articles [106]
Editorials [3]
Conferences [84]
elearning [20]
ESMO/JSMO Joint Symposium: Biomarkers and selected therapeutics in lung and GI cancer
ESMO/JSMO Joint Symposium: Biomarkers and selected therapeutics in lung and GI cancer
ESMO 35: Final results from landmark trial confirm survival benefits of EGFR mutations in lung cancer
ESMO 35: Final results from landmark trial confirm survival benefits of EGFR mutations in lung cancer
ESMO 35: New Phase II study shows first-line promise of lung cancer drug PF-299
ESMO 35: New Phase II study shows first-line promise of lung cancer drug PF-299
Latest news from EMSO for Avastin (bevacizumab)
Latest news from EMSO for Avastin (bevacizumab)
ESMO 35: Erlotinib improves progression-free survival as first-line therapy in advanced lung cancer
ESMO 35: Erlotinib improves progression-free survival as first-line therapy in advanced lung cancer
ESMO 35: New targeted therapy adds benefit to erlotinib in some patients with advanced lung cancer
ESMO 35: New targeted therapy adds benefit to erlotinib in some patients with advanced lung cancer
Melanoma uses body's immune system to spread to lungs
Melanoma uses body's immune system to spread to lungs
Early lung cancer detection
Early lung cancer detection
Research finds half of advanced lung cancer patients receive chemotherapy
Research finds half of advanced lung cancer patients receive chemotherapy
Selenium associated with a lower risk of bladder cancer
Selenium associated with a lower risk of bladder cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation